InvestmentWednesday, October 21, 2026
Archimed invests in Organika
Archimed has invested in Organika, a Vancouver-based nutraceutical company founded in 1990, in the first deal from the MED IV fund.
Archimed has invested in Organika, a Vancouver-headquartered nutraceutical company. The transaction is the first investment from Archimed’s MED IV fund.
Organika was founded in 1990 and makes supplements spanning hydration, collagen, protein, immunity, gut health and sleep.
Deal facts
- Target
- Organika
- Business
- Vancouver-based nutraceutical company making supplements across hydration, collagen, protein, immunity, gut health and sleep.
- Buyer
- Archimed
- Sponsor
- Archimed
- Deal type
- Investment
- Headquarters
- Vancouver, Canada
- Status
- Completed
- Announced
- Wednesday, October 21, 2026
Sources
- PEI Private EquityOct 21, 2026
Written by Buyout Desk from the sources above. Spotted an error? Email corrections@buyoutdesk.com.